New report highlights biopharmaceutical industry’s commitment to D&I

Today, PhRMA released a new report prepared by TEConomy Partners, LLC that provides insights into the efforts of biopharmaceutical companies to advance diversity & inclusion (D&I) in the workplace, in the communities in which they operate and in the patient communities in which they serve. The report examines the state of accelerating demographic changes and persistent workforce disparities both broadly in corporate America and within the biopharmaceutical industry. The report compiles insights into how the biopharmaceutical industry is increasing opportunities and addressing workplace disparities for underrepresented and underserved populations.